SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
-----------------------
Date of report (Date of earliest event reported): December 21, 2001
CYTRX CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 000-15327 58-1642750
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
154 Technology Parkway
Suite 200
Norcross, Georgia 30092
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (770) 368-9500
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS.
This Current Report on Form 8-K/A amends the Current Report on Form 8-K
filed by CytRx Corporation on December 21, 2001 by refiling the license
agreement between CytRx and Vical Incorporated together with the schedules and
addenda to the agreement as an exhibit hereto.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) The following exhibits are filed as part of this Current Report on
Form 8-K:
EXHIBIT NO. DESCRIPTION
----------- -----------
99 License Agreement between Vical Incorporated
and CytRx Corporation*
* Confidential treatment has been requested with respect to certain portions of
this agreement.
ii
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report on Form 8-K/A to be signed on its
behalf by the undersigned hereunto duly authorized.
CYTRX CORPORATION
By: /s/ Mark W. Reynolds
----------------------------------------
Name: Mark W. Reynolds
--------------------------------------
Title: Vice President, Finance
-------------------------------------
Dated: May 13, 2002
iii